Search

Author/Creator Imperoli, Giuseppe

1. ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation. (18th May 2022)

Authors:
Di Fusco, Stefania Angela; Gronda, Edoardo; Mocini, Edoardo; Lucà, Fabiana; Bisceglia, Irma; De Luca, Leonardo; Caldarola, Pasquale; Cipriani, Manlio; Corda, Marco; De Nardo, Alfredo; Francese, Giuseppina Maura; Napoletano, Cosimo; Navazio, Alessandro; Riccio, Carmine; Roncon, Loris; Tizzani, Ema...
Journal:
European heart journal supplements
Issue:
Volume 24(2022)Supplement C
Page Start:
C272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target. Issue 1 (14th March 2022)

Authors:
Di Fusco, Stefania Angela; Arca, Marcello; Scicchitano, Pietro; Alonzo, Alessandro; Perone, Francesco; Gulizia, Michele Massimo; Gabrielli, Domenico; Oliva, Fabrizio; Imperoli, Giuseppe; Colivicchi, Furio
Journal:
Heart
Issue:
Volume 109:Issue 1(2023)
Page Start:
18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Potential pathophysiologic mechanisms underlying the inherent risk of cancer in patients with atherosclerotic cardiovascular disease. (15th September 2022)

Authors:
Di Fusco, Stefania Angela; Cianfrocca, Cinzia; Bisceglia, Irma; Spinelli, Antonella; Alonzo, Alessandro; Mocini, Edoardo; Gulizia, Michele Massimo; Gabrielli, Domenico; Oliva, Fabrizio; Imperoli, Giuseppe; Colivicchi, Furio
Journal:
International journal of cardiology
Issue:
Volume 363(2022)
Page Start:
190
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗